Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Refractory Solid Tumours”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT06880549
What this trial is testing

MRNA-4106 or mRNA-4200 Administered Alone or in Combination With Anti-Cancer Agents in Participants With Solid Tumors

Who this might be right for
Advanced Solid Tumors
ModernaTX, Inc. 42
Early research (Phase 1)Study completedNCT01478685
What this trial is testing

CC-486 as a Single Agent and in Combination With Carboplatin or ABI-007 in Subjects With Relapsed or Refractory Solid Tumors

Who this might be right for
Urinary Bladder NeoplasmsCarcinoma, Transitional CellOvarian Neoplasms+5 more
Celgene 169
Early research (Phase 1)WithdrawnNCT05231733
What this trial is testing

Study of SPX-101 in Subjects With Advanced or Refractory Solid Tumors

Who this might be right for
Solid Tumors
SparX Biotech(Jiangsu) Co., Ltd.
Testing effectiveness (Phase 2)Study completedNCT01771458
What this trial is testing

Phase II Trial Comparing Therapy Based on Tumor Molecular Profiling Versus Conventional Therapy in Patients With Refractory Cancer

Who this might be right for
Reccurent/Metastatic Solid Tumor Disease
Institut Curie 742
Not applicableStudy completedNCT00890435
What this trial is testing

Decision Making About Participating in Pharmacokinetic Studies in Patients Enrolled in a Phase I Treatment Clinical Trial

Who this might be right for
Brain and Central Nervous System TumorsLeukemiaUnspecified Adult Solid Tumor, Protocol Specific+1 more
Children's Oncology Group 53
Early research (Phase 1)Active Not RecruitingNCT04483778
What this trial is testing

B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults

Who this might be right for
Pediatric Solid TumorGerm Cell TumorRetinoblastoma+14 more
Seattle Children's Hospital 68
Very early researchNot Yet RecruitingNCT06951425
What this trial is testing

An Exploratory Clinical Study of the Efficiency and Safety of TH027 in the Treatment of Relapsed/Refractory Solid Tumors

Who this might be right for
Solid Tumors
Shanghai Tongji Hospital, Tongji University School of Medicine 24
Testing effectiveness (Phase 2)Looking for participantsNCT06150885
What this trial is testing

A Safety And Efficacy Study Of Allogeneic CAR Gamma-Delta T Cells in Subjects With Relapsed/Refractory Solid Tumors

Who this might be right for
Solid Tumor
Ever Supreme Bio Technology Co., Ltd. 60
Early research (Phase 1)Study completedNCT00379132
What this trial is testing

131-I-TM-601 Study in Adults With Solid Tumors

Who this might be right for
Breast CancerNon-Small Cell Lung CancerMelanoma+5 more
TransMolecular 60
Early research (Phase 1)Study completedNCT00003451
What this trial is testing

Interleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT05715281
What this trial is testing

Testing the Combination of Anti-cancer Drugs Atezolizumab and Tiragolumab in People With Advanced Stage Rare Cancers, RARE3 Trial

Who this might be right for
Advanced Rare Malignant Solid NeoplasmRare Malignant Solid NeoplasmRefractory Rare Malignant Solid Neoplasm
National Cancer Institute (NCI) 12
Very early researchNot Yet RecruitingNCT07621471
What this trial is testing

IL-15 Enhanced NK Cell Therapy for Solid Tumors

Who this might be right for
Solid TumorsMetastatic Cancer
Genovn Therapeutics (Suzhou) Co., Ltd. 12
Early research (Phase 1)Looking for participantsNCT07492628
What this trial is testing

Dual-Target Nectin-4/HER2 CAR-NK Cells in Advanced Urothelial Carcinoma

Who this might be right for
Bladder CancerUrothelial CarcinomaMetastatic Urothelial Carcinoma+2 more
Beijing Biotech 42
Early research (Phase 1)Study completedNCT01132911
What this trial is testing

A Phase I Study of Vorinostat and Bortezomib in Children With Refractory of Recurrent Solid Tumors, Including CNS Tumors and Lymphomas

Who this might be right for
LymphomaSarcomaWilmsTumor+1 more
National Cancer Institute (NCI) 5
Testing effectiveness (Phase 2)Study completedNCT00514267
What this trial is testing

An Open-Label Study of YM155 + Docetaxel in Subjects With Advanced Hormone Refractory Prostate Cancer and Other Solid Tumors

Who this might be right for
Prostate CancerTumors
Astellas Pharma Inc 32
Early research (Phase 1)Active Not RecruitingNCT02389309
What this trial is testing

Dasatinib, Temsirolimus, and Cyclophosphamide in Treating Patients With Advanced, Recurrent, or Refractory Solid Tumors

Who this might be right for
Advanced Malignant Solid NeoplasmRecurrent Brain NeoplasmRecurrent Malignant Solid Neoplasm+1 more
M.D. Anderson Cancer Center 14
Testing effectiveness (Phase 2)Looking for participantsNCT05144698
What this trial is testing

RAPA-201 Therapy of Solid Tumors

Who this might be right for
Solid TumorSmall Cell and Non-small Cell Lung CancerHead and Neck Cancer+6 more
Rapa Therapeutics LLC 37
Early research (Phase 1)Study completedNCT00012181
What this trial is testing

Flavopiridol in Treating Children With Relapsed or Refractory Solid Tumors or Lymphomas

Who this might be right for
Recurrent Childhood Brain Stem GliomaRecurrent Childhood Cerebellar AstrocytomaRecurrent Childhood Cerebral Astrocytoma+19 more
National Cancer Institute (NCI) 30
Early research (Phase 1)Not Yet RecruitingNCT06710821
What this trial is testing

Irinotecan Liposomes Combined with Temozolomide and Vincristine in the Treatment of Pediatric Patients with Solid Tumors

Who this might be right for
Solid Tumor Cancer
Yizhuo Zhang 40
Early research (Phase 1)Study completedNCT00110357
What this trial is testing

Study of Erbitux™ (Cetuximab) in Pediatric Patients With Refractory Solid Tumors

Who this might be right for
CancerRefractory Solid Tumor
Eli Lilly and Company 48
Next Page